Summary
In a previous study we were able to show that in women over the age of 45 the level of 1,25-dihydroxyvitamin D (1,25(OH)2D) in bone, but not in serum, is significantly reduced when compared with younger women. In the present study we measured the concentration of 1,25(OH)2D in sera and bones of 19 female patients with subcapital fractures of the femur, mean age 78±2 years. We were able to show that serum levels of 1,25(OH)2D were within the normal range, while bone levels were markedly reduced compared to levels in femoral bone obtained from young female cadavers or to the previously reported levels in non-osteoporotic elderly women. Thus, reduced levels of 1,25(OH)2D in bones of elderly women may lead, together with other factors, to subcapital fractures.
This is a preview of subscription content, log in via an institution to check access.
References
Avioli LV, Lindsay R (1990) The female osteoporotic syndrome(s). In: Avioli LV, Krane SM (eds) Metabolic bone diseases and clinical related disorders. WB Saunders, Philadelphia, pp 436–437
Melton LJ, Riggs BL (1987) Epidemiology of age-related fractures. In: Avioli LV (ed) The osteoporosis syndrome. Detection, prevention and treatment. Grane & Stratton, Inc. Orlando, pp 1–30
Lane JM, Vigorita VJ (1983) Osteoporosis. J Bone Joint Surg G5A:274–278
Need AG, Horowitz M, Philcox JC, Nordin BEC (1988) 1,25-dihydroxycalciferol and calcium therapy in osteoporosis with calcium malabsorption. Miner Electrolyte Metab 11:35–40
Brommage R, DeLuca HF (1985) Evidence that 1,25-dihydroxyvitamin D3 is the physiologically active metabolite of vitamin D3. Endo Rev 6:791–811
DeLuca HF (1976) Recent advances in our understanding of the vitamin D endocrine system. J Lab Clin Med 87:7–26
Kumar R, Cohen WR, Silva P, Epstein FH (1979) Elevated 1,25-dihydroxyvitamin D; plasma levels in normal human pregnancy and lactation. J Clin Invest 63:342–344
Chesney RW, Rosen JF, Hamstra AJ, DeLuca HF (1980) Serum 1,25-dihydroxyvitamin D levels in normal children and in vitamin D disorders. A J Dis Child 134:135–139
Gallagher JC (1990) The basis for 1,25-dihydroxyvitamin D therapy in the treatment of osteoporosis. In: DeLuca HF, Mazes R (eds) Osteoporosis. Physiological basis assessment and treatment. Elsevier Science Publ. New York, pp 195–199
Sagiv P, Lidor C, Hallel T, Edelstein S (1992) Decrease in bone level of 1,25-dihydroxyvitamin D in women over 45 years old. Calcif Tissue Int 81:24–26
Edelstein S, Charman M, Lawson DEM, Kodicek E (1974) Competitive protein-binding assay for 25-hydroxycholecalciferol. Clin Sci Elec Med 46:231–240
Eisman J, Hamstra A, Kream BE, DeLuca HF (1976) A sensitive precise and convenient method for determination of 1,25-dihydroxy-vitamin D in human plasma. Arch Biochem Biophys 170:235–243
Slovick DM, Adams JS, Neer RM, Holick MF, Potts JT (1981) Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med 305:372–375
Weisman Y, Schen RJ, Eisenberg S, Edelstein S, Harell A (1981) Inadequate status and impaired metabolism of vitamin D in the elderly. Isr J Med Sci 17:19–21
Tilyard MW, George B, Spears FS, Thomson J, Dovey S (1992) Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 326:357–362
DeLuca HF (1990) Osteoporosis and the metabolites of vitamin D. Metabolism 39: Suppl 1:3–9
Author information
Authors and Affiliations
Additional information
Holder of Prof. T. Reichstein Professorial Chair
Rights and permissions
About this article
Cite this article
Lidor, C., Sagiv, P., Amdur, B. et al. Decrease in bone levels of 1,25-dihydroxyvitamin D in women with subcapital fracture of the femur. Calcif Tissue Int 52, 146–148 (1993). https://doi.org/10.1007/BF00308324
Issue Date:
DOI: https://doi.org/10.1007/BF00308324